Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Intera Oncology

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Intera Oncology

Regulatory records
2
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 2 FDA records to the applicant name Intera Oncology. 1 entry is a PMA supplement. 1 entry is a 30-day notice. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Feb 26, 2026 to Mar 16, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code LKK appears in 2 of the 2 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P890055, with 2 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: 180 Wells Ave., Suite 300a, Newton, MA, 02459. Recorded on P890055/S093, decision dated Mar 16, 2026.

Changes described in PMA records

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Regulatory record history

Product / regulatory recordCompanyPathwayDecision dateSource
Intera OncologyPMA supplementMar 16, 2026FDA
Intera OncologyPMA supplementFeb 26, 2026FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 20, 2026.